Can you provide the average price target for ERASCA INC stock?
17 analysts have analysed ERAS and the average price target is 16.32 USD. This implies a price decrease of -4.06% is expected in the next year compared to the current price of 17.01.
ERASCA INC (ERAS) Forecast, Price Target & Analyst Ratings
NASDAQ:ERAS • US29479A1088
Current stock price
17.01 USD
-0.35 (-2.02%)
At close:
19.44 USD
+2.43 (+14.29%)
Pre-Market:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for ERASCA INC (ERAS).
Forecast Snapshot
Next Earnings Forecast
Earnings Estimate- Release Date
- May 7, 2026
- Period
- Q1 / 2026
- EPS Estimate
- -$0.21
- Revenue Estimate
Price Target Details & History
Consensus Price Target and Range
Mean target
$16.32
Upside
-4.06%
From current price of $17.01 to mean target of $16.32, Based on 17 analyst forecasts
Low
$2.02
Median
$19.89
High
$25.20
Price Target Revisions
1 Month
55.34%
3 Months
227.27%
Price Target Summary
17 Wall Street analysts provided a forecast for the next 12 months for ERAS. The average price target is 16.32 USD. This implies a price decrease of -4.06% is expected in the next year compared to the current price of 17.01.
The average price target has been revised upward by 227.27% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
81.18%
ERAS was analyzed by 17 analysts. The buy percentage consensus is at 81. So analysts seem to be very confident about ERAS.
In the previous month the buy percentage consensus was at a similar level.
ERAS was analyzed by 17 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-03-18 | JP Morgan | Maintains | Overweight -> Overweight |
| 2026-03-16 | Guggenheim | Maintains | Buy -> Buy |
| 2026-03-13 | Mizuho | Maintains | Outperform -> Outperform |
| 2026-03-13 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2026-03-13 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2026-03-06 | Clear Street | Maintains | Buy -> Buy |
| 2026-01-26 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2026-01-16 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2026-01-13 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2026-01-07 | Piper Sandler | Initiate | Overweight |
| 2025-12-09 | Mizuho | Maintains | Outperform -> Outperform |
| 2025-11-14 | Guggenheim | Maintains | Buy -> Buy |
| 2025-10-16 | Stifel | Initiate | Buy |
| 2025-09-03 | B of A Securities | Downgrade | Buy -> Underperform |
| 2025-08-18 | Morgan Stanley | Downgrade | Overweight -> Equal-Weight |
| 2025-04-30 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-03-26 | Raymond James | Initiate | Outperform |
| 2025-03-21 | Goldman Sachs | Maintains | Buy -> Buy |
| 2025-03-21 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-01-07 | B of A Securities | Upgrade | Neutral -> Buy |
| 2024-11-18 | Jefferies | Initiate | Buy |
| 2024-11-13 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-10-25 | Goldman Sachs | Maintains | Buy -> Buy |
| 2024-10-25 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-08-14 | Goldman Sachs | Maintains | Buy -> Buy |
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- May 7, 2026
- Period
- Q1 / 2026
- EPS Estimate
- -$0.21
- Revenue Estimate
- Revenue Q2Q
- N/A
- EPS Q2Q
- -94.73%
- Number of Analysts
- 12
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
-90.91%
EPS (3 Months)
-87.50%
Next Earnings Summary
ERAS is expected to report earnings on 5/7/2026. The consensus EPS estimate for the next earnings is -0.21 USD and the consensus revenue estimate is 0 USD.
Full Analyst Estimates 2026 - 2033
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A 877.78% | N/A 326.50% | N/A 1,500.03% | N/A 112.08% | N/A 117.82% | N/A 49.28% | ||||||||
| EBITDA YoY % growth | -12.98M | -36.96M -184.75% | -95.71M -158.96% | -142.81M -49.21% | -137.793M 3.51% | -148.582M -7.83% | -128.298M 13.65% | N/A -48.55% | N/A 3.45% | N/A -23.58% | N/A 5.28% | N/A 35.93% | N/A -67.03% | N/A 203.13% | N/A 165.10% | |
| EBIT YoY % growth | -13.29M | -37.5M -182.17% | -96.54M -157.44% | -145.45M -50.66% | -141.525M 2.70% | -152.387M -7.67% | -131.405M 13.77% | N/A -43.20% | N/A -2.87% | N/A -18.23% | N/A -25.48% | N/A 62.09% | N/A 229.65% | N/A 432.12% | N/A 71.50% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | -1.96 16.33% | -0.83 57.65% | -0.74 10.84% | -0.44 40.54% | N/A -26.21% | N/A 3.47% | N/A -24.95% | N/A -21.52% | N/A 27.94% | N/A 59.13% | N/A 400.00% | N/A 108.51% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.21 -94.73% | -0.11 10.27% | -0.11 -3.03% | -0.12 -21.27% | -0.13 40.48% | -0.14 -27.89% | -0.15 -28.25% | -0.15 -26.17% |
| Revenue Q2Q % growth | ||||||||
| EBITDA Q2Q % growth | -88.135M -153.20% | -38.746M -33.53% | -40.368M -33.75% | -39.314M -33.28% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -74.209M -108.28% | -37.878M -23.68% | -40.198M -23.51% | -41.548M -27.43% | -49.266M 33.61% | -53.346M -40.84% | -57.426M -42.86% | -62.526M -50.49% |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
-15.04%
EPS Next 5 Year
-5.92%
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
-15.83%
EBIT Next 5 Year
1.11%
ERASCA INC / ERAS Forecast FAQ
What is the next earnings date for ERAS stock?
ERASCA INC (ERAS) will report earnings on 2026-05-07, after the market close.
What are the consensus estimates for ERASCA INC (ERAS) next earnings?
The consensus EPS estimate for the next earnings of ERASCA INC (ERAS) is -0.21 USD and the consensus revenue estimate is 0 USD.
Can you provide the analyst count for ERASCA INC stock?
The number of analysts covering ERASCA INC (ERAS) is 17.